Fate Therapeutics to Present at 23rd Annual Needham Virtual Healthcare Conference

Rhea-AI Summary

Fate Therapeutics, Inc. (NASDAQ: FATE) will present at the 23rd Annual Needham Virtual Healthcare Conference to discuss their iPSC-derived cellular immunotherapies for cancer and autoimmune disorders. The webcast will be available on the company's website for viewing after the event.

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders, today announced that the Company will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024 at 2:15 PM ET.

A live webcast, if recorded, of each presentation can be accessed under “Events & Presentations” in the Investors section of the Company’s website at www.fatetherapeutics.com. The archived webcast will be available on the Company’s website shortly after the event.

About Fate Therapeutics, Inc.

Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders. Using its proprietary iPSC product platform, the Company has established a leadership position in creating multiplexed-engineered iPSC lines and in the manufacture and clinical development of off-the-shelf, iPSC-derived cell products. The Company’s pipeline includes iPSC-derived natural killer (NK) cell and T-cell product candidates, which are selectively designed, incorporate novel synthetic controls of cell function, and are intended to deliver multiple therapeutic mechanisms to patients. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.

Contact:
Christina Tartaglia
Stern Investor Relations, Inc.
212.362.1200
christina.tartaglia@sternir.com

FAQ

When will Fate Therapeutics present at the 23rd Annual Needham Virtual Healthcare Conference?

Fate Therapeutics will present at the 23rd Annual Needham Virtual Healthcare Conference on Wednesday, April 10, 2024 at 2:15 PM ET.

What is the focus of Fate Therapeutics' pipeline?

Fate Therapeutics is dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune disorders.

Where can the webcast of Fate Therapeutics' presentation be accessed?

The live webcast, if recorded, can be accessed under 'Events & Presentations' in the Investors section of the Company’s website at www.fatetherapeutics.com.

When will the archived webcast of Fate Therapeutics' presentation be available?

The archived webcast will be available on the Company’s website shortly after the event.